89bio ETNB 深 沪
已收盘 10-30 16:00:00 美东时间
14.84
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 14.84
- 总市值 21.96亿
- 52周最高 15.06
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.16
- 委 比 0.00%
- 总股本 1.48亿
- 历史最高 47.253
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.00
- 每 手 1
- 风险率 2.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug Inventiva shares up 50% in January Optimism builds around its MASH drug Big Pharma signal strategic interest A lot riding out Phase 3 outcome Evaluating funding options, CEO tells Reuters By Danilo Masoni MILAN, Jan 28 (Re
01-28 23:36
Cantor Fitzgerald Suspends Overweight Rating on 89bio
Cantor Fitzgerald suspends Overweight rating on 89bio (NASDAQ:ETNB).
2025-10-31 21:47
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-10-17 11:58
Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Viking Therapeutics (NASDAQ:VKTX) and other biotechs advancing drugs for a liver disease called metabolic dysfunction-associated steatohepatitis (MASH) gained on Thursday as the MASH space witnessed t...
2025-10-09 23:33
Roche Launches Tender Offer To Acquire 89bio For $14.50/Share, Plus A Non-Tradeable Contingent Value Right To Receive Certain Milestone Payments Of Up To An Aggregate Of $6.00 Per Share In Cash; Tender Offer Is Being Made Pursuant To The Previously Announced Merger Agreement Dated As Of September 17, 2025
Roche ((SIX: RO, ROG, OTCQX:RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of 89bio, Inc. (89bio) (NASDAQ:ETNB) at a price of $14.50 per share in cash, plus
2025-10-02 04:34
Goldman's 48 potential M&A candidates
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
2025-09-29 03:14
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
2025-09-22 18:44
美股周涨跌榜 | 核电股Oklo周涨超63%，有消息称特朗普政府正全力推进大型电力项目建设；RGTI周涨近50%
核电股Oklo周涨超63%，有消息称特朗普政府正全力推进大型电力项目建设；RGTI周涨近50%，与美国空军研究实验室合作推进超导昆腾网络技术>>
2025-09-20 10:40
每日全球并购：罗氏将收购生物制药公司89bio | 百健宣布收购Alcyone Therapeutics（9/19）
登录新浪财经APP 搜索【信披】查看更多考评等级 -每日资讯- 1、甘肃国投拟收购兰石重装 甘肃省国资委拟将其持有的兰石集团90...
2025-09-19 20:27
Wolfe Research Downgrades 89bio to Peer Perform
Wolfe Research analyst Andy Chen downgrades 89bio (NASDAQ:ETNB) from Outperform to Peer Perform.
2025-09-19 19:53
